Household Health Spending Calculator September 10, 2024 Interactive This interactive tool, updated with 2022 data, helps users understand health care costs vary by family size, income, insurance, and health status. Use the dropdown menus to explore scenarios and trends in household health spending.
KFF Health Tracking Poll September 2024: Support for Reducing Prescription Drug Prices Remains High, Even As Awareness of IRA Provisions Lags September 13, 2024 Poll Finding More than two years ago President Biden signed into law Medicare drug pricing provisions in the Inflation Reduction Act. KFF’s September Health Tracking Poll examines voter’s views on these provisions and finds that large majorities of voters are unaware of the provisions despite reporting support for them.
Allowing Medicare to Negotiate Drug Prices Remains Broadly Popular Among Voters, Though Most Are Unaware of the Law and Its Projected Savings September 13, 2024 News Release Allowing Medicare to negotiate drug prices on behalf of older Americans remains broadly popular across partisans, though many voters are unaware of the new law and the billions of dollars it is expected to save in 2026, a new KFF Health Tracking Poll finds.A large majority (85%) of voters say…
One or Two Health Systems Controlled the Entire Market for Inpatient Hospital Care in Nearly Half of Metropolitan Areas in 2022 October 1, 2024 Issue Brief This analysis examines the competitiveness of markets for hospital care based on the share of metropolitan areas controlled by a small number of independent hospitals or health systems and other measures. It finds that nearly half of metropolitan areas across the country had only one or two hospitals or health systems providing general inpatient hospital care in 2022.
Medicare Spending on Ozempic and Other GLP-1s Is Skyrocketing March 22, 2024 Blog This policy watch analyzes the latest data on Medicare Part D spending on GLP-1 drugs, initially approved to treat diabetes but in high demand as treatments for obesity, and shows how spending on these drugs has increased substantially in recent years.
Gross Medicare Spending on Ozempic and Other GLP-1s Is Already Skyrocketing – Even Though Medicare Cannot Cover The Drugs for Weight Loss March 23, 2024 News Release A KFF analysis shows that gross total Medicare spending on Ozempic and other similar drugs has increased dramatically in recent years – even though Medicare is explicitly prohibited by law from covering the drugs for obesity. That’s because Medicare now covers the drugs, known as GLP-1s, for other medically accepted…
Ten Things to Know About Consolidation in Health Care Provider Markets April 19, 2024 News Release Mergers and acquisitions involving hospitals and other health care providers are drawing attention from federal and state regulators, including the Federal Trade Commission, and policymakers amid concerns that such consolidations can reduce competition and contribute to the high costs of health care. A new KFF brief examines and summarizes the…
The Estimated Value of Tax Exemption for Nonprofit Hospitals Was About $28 Billion in 2020 March 14, 2023 Issue Brief This data note estimates that the value of tax exemption for nonprofit hospitals was $28 billion in 2020. This amount exceeds estimated charity care costs among nonprofit hospitals in 2020 ($16 billion), though charity care represents only a portion of the community benefits reported by nonprofit hospitals.
Nonprofit Hospitals’ Tax-Exempt Status Worth About $28 Billion, New KFF Analysis Finds March 14, 2023 News Release Editor’s Note: The press release was updated on March 27, 2023, to reflect corrections in the underlying analysis, resulting in a modest increase in the total estimated value of tax exemption, from $27.6 to $28.1 billion. The tax-exempt status of the nation’s nonprofit hospitals collectively was worth about $28 billion…
Americans’ Challenges with Health Care Costs March 1, 2024 Issue Brief This data note reviews our recent polling data that finds that Americans struggle to afford many aspects of health care, including disproportionate shares of uninsured adults, Black and Hispanic adults and those with lower incomes.